Ataxia, Cerebellar
11
2
4
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
75.0%
-11.5% vs benchmark
9%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
At Home Use of Stimulation Suits for Managing MS Symptoms
Efficacy of tDCS in Degenerative Ataxia
Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)
Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)
tDCS Associated With Locomotor Training on Functional Mobility of Cerebellar Ataxia
Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy
Reading Problems Associated With Central Nervous System (CNS) Pathologies.
Effect of Nilotinib in Cerebellar Ataxia Patients
Efficacy of Lycra Garments in Ataxic Subjects
Neuromodulation of Social Skills in Childhood Ataxia
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia